Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2005 1
2008 1
2009 1
2012 1
2014 1
2015 1
2016 2
2017 2
2018 1
2019 1
2020 1
2021 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
The wonderful colors of the hematoxylin-eosin stain in diagnostic surgical pathology.
Chan JK. Chan JK. Int J Surg Pathol. 2014 Feb;22(1):12-32. doi: 10.1177/1066896913517939. Epub 2014 Jan 9. Int J Surg Pathol. 2014. PMID: 24406626 Review.
This review discusses the spectrum, intensity, and texture of colors observed in H&E-stained slides to illustrate their value in surgical pathology diagnosis. ...Extracellular eosinophilic deposits can be produced by many conditions, but amyloid and monoclonal …
This review discusses the spectrum, intensity, and texture of colors observed in H&E-stained slides to illustrate their value in …
Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study.
Joly F, Cohen C, Javaugue V, Bender S, Belmouaz M, Arnulf B, Knebelmann B, Nouvier M, Audard V, Provot F, Gnemmi V, Nochy D, Goujon JM, Jaccard A, Touchard G, Fermand JP, Sirac C, Bridoux F. Joly F, et al. Blood. 2019 Feb 7;133(6):576-587. doi: 10.1182/blood-2018-09-872028. Epub 2018 Dec 21. Blood. 2019. PMID: 30578255 Free article.
Monoclonal immunoglobulin deposition disease (MIDD) is a rare complication of B-cell clonal disorders, defined by Congo red negative-deposits of monoclonal light chain (LCDD), heavy chain (HCDD), or both (LHCDD). ...FLC response VGPR and absence of sev …
Monoclonal immunoglobulin deposition disease (MIDD) is a rare complication of B-cell clonal disorders, defined b …
Randall-Type Monoclonal Immunoglobulin Deposition Disease in Bone Scintigraphy.
Jacquet-Francillon N, Dijoud F, Karlin L, Dietz M, Flaus A, Tordo J. Jacquet-Francillon N, et al. Clin Nucl Med. 2023 Dec 1;48(12):e611-e613. doi: 10.1097/RLU.0000000000004927. Epub 2023 Oct 23. Clin Nucl Med. 2023. PMID: 37883135
Bone scintigraphy is recognized as a noninvasive alternative to endomyocardial biopsy for the diagnostic of wild-type (wATTR) and hereditary ATTR amyloidosis (hATTR). Light chain amyloidosis (AL), Randall-type monoclonal immunoglobulin deposition disease …
Bone scintigraphy is recognized as a noninvasive alternative to endomyocardial biopsy for the diagnostic of wild-type (wATTR) and hereditary …
Monoclonal gammopathy of renal significance: Spectrum of diseases and approach to a case.
Tewari R, Chatterjee T, Mendonca S, Dogra M, Pramanik SK, Yanamandra U. Tewari R, et al. Saudi J Kidney Dis Transpl. 2021 Mar-Apr;32(2):298-306. doi: 10.4103/1319-2442.335440. Saudi J Kidney Dis Transpl. 2021. PMID: 35017322 Review.
Hence, these lesions require therapeutic intervention even if they do not satisfy myeloma criteria or the presence of any myeloma defining event. The spectrum of renal lesions that can be observed in a case of MGRS is wide and mirrors the list that may be seen in a case of …
Hence, these lesions require therapeutic intervention even if they do not satisfy myeloma criteria or the presence of any myeloma defining e …
Outcomes of patients with renal monoclonal immunoglobulin deposition disease.
Kourelis TV, Nasr SH, Dispenzieri A, Kumar SK, Gertz MA, Fervenza FC, Buadi FK, Lacy MQ, Erickson SB, Cosio FG, Kapoor P, Lust JA, Hayman SR, Rajkumar V, Zeldenrust SR, Russell SJ, Dingli D, Lin Y, Gonsalves W, Lorenz EC, Zand L, Kyle RA, Leung N. Kourelis TV, et al. Am J Hematol. 2016 Nov;91(11):1123-1128. doi: 10.1002/ajh.24528. Epub 2016 Aug 29. Am J Hematol. 2016. PMID: 27501122 Free article.
Recent reports suggest that deep hematologic responses to chemotherapy are associated with improved renal outcomes in monoclonal immunoglobulin deposition disease (MIDD). Here we describe the long term outcomes and identify prognostic factors after fir …
Recent reports suggest that deep hematologic responses to chemotherapy are associated with improved renal outcomes in monoclonal i …
Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens.
Ziogas DC, Kastritis E, Terpos E, Roussou M, Migkou M, Gavriatopoulou M, Spanomichou D, Eleutherakis-Papaiakovou E, Fotiou D, Panagiotidis I, Kafantari E, Psimenou E, Boletis I, Vlahakos DV, Gakiopoulou H, Matsouka C, Dimopoulos MA. Ziogas DC, et al. Leuk Lymphoma. 2017 Aug;58(8):1832-1839. doi: 10.1080/10428194.2016.1267349. Epub 2016 Dec 14. Leuk Lymphoma. 2017. PMID: 27967286
Monoclonal immunoglobulin deposition disease (MIDD) is characterized by non-organized immunoglobulin-fragments along renal basement membranes with subsequent organ deterioration. ...Among patients with CR or VGPR, median eGFR improvement was 7.7 ml/min …
Monoclonal immunoglobulin deposition disease (MIDD) is characterized by non-organized immunoglobulin-fragments a …
Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach.
Pianko MJ, Tiutan T, Derkach A, Flynn J, Salvatore SP, Jaffer-Sathick I, Rossi AC, Lahoud O, Hultcrantz M, Shah UA, Maclachlan K, Chung DJ, Shah GL, Landau HJ, Korde N, Mailankody S, Lesokhin AM, Tan C, Scordo M, Jaimes EA, Giralt SA, Usmani S, Hassoun H. Pianko MJ, et al. Am J Hematol. 2023 Mar;98(3):421-431. doi: 10.1002/ajh.26801. Epub 2023 Jan 1. Am J Hematol. 2023. PMID: 36588413 Free PMC article.
Monoclonal immunoglobulin deposition disease (MIDD), often associated with plasma cell dyscrasias, predominantly affects the kidneys. ...All 6 patients (100%) with isolated proteinuria and 7 of 13 (54%) with isolated decreased eGFR achieved renal respo …
Monoclonal immunoglobulin deposition disease (MIDD), often associated with plasma cell dyscrasias, predominantly …
Renal monoclonal immunoglobulin deposition disease: the disease spectrum.
Lin J, Markowitz GS, Valeri AM, Kambham N, Sherman WH, Appel GB, D'Agati VD. Lin J, et al. J Am Soc Nephrol. 2001 Jul;12(7):1482-1492. doi: 10.1681/ASN.V1271482. J Am Soc Nephrol. 2001. PMID: 11423577
This study reports the clinicopathologic findings and outcome in 34 patients with renal monoclonal immunoglobulin deposition disease (MIDD), which included 23 light-chain DD (LCDD), 5 light- and heavy-chain DD (LHCDD), and 6 heavy-chain DD (HCDD). ...C …
This study reports the clinicopathologic findings and outcome in 34 patients with renal monoclonal immunoglobulin depositio …
Clinicopathological features and prognosis in immunoglobulin light and heavy chain deposition disease.
Masai R, Wakui H, Togashi M, Maki N, Ohtani H, Komatsuda A, Sawada K. Masai R, et al. Clin Nephrol. 2009 Jan;71(1):9-20. doi: 10.5414/cnp71009. Clin Nephrol. 2009. PMID: 19203545
BACKGROUND: There are three subtypes of monoclonal immunoglobulin deposition disease: light chain deposition disease (LCDD), light and heavy chain deposition disease (LHCDD), and heavy chain deposition disease (HCDD). ...All patients with LHCDD were tr …
BACKGROUND: There are three subtypes of monoclonal immunoglobulin deposition disease: light chain deposition dis …
Monoclonal immunoglobulin deposition disease associated with membranous features.
Komatsuda A, Masai R, Ohtani H, Togashi M, Maki N, Sawada K, Wakui H. Komatsuda A, et al. Nephrol Dial Transplant. 2008 Dec;23(12):3888-94. doi: 10.1093/ndt/gfn363. Epub 2008 Jul 2. Nephrol Dial Transplant. 2008. PMID: 18596130
BACKGROUND: Very few cases of non-organized and non-Randall-type monoclonal immunoglobulin deposition disease (MIDD) associated with membranous features have been reported. ...All patients were treated with steroids, and good effects were observed …
BACKGROUND: Very few cases of non-organized and non-Randall-type monoclonal immunoglobulin deposition disease (M …
17 results